Atomistry » Chlorine » PDB 3fzn-3g71 » 3g0u
Atomistry »
  Chlorine »
    PDB 3fzn-3g71 »
      3g0u »

Chlorine in PDB 3g0u: Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4

Enzymatic activity of Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4

All present enzymatic activity of Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4:
1.3.3.1;

Protein crystallography data

The structure of Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4, PDB code: 3g0u was solved by M.Davis, T.Heikkila, G.A.Mcconkey, C.W.G.Fishwick, M.R.Parsons, A.P.Johnson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 78.59 / 2.00
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 90.752, 90.752, 122.799, 90.00, 90.00, 120.00
R / Rfree (%) 17 / 20.3

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4 (pdb code 3g0u). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4, PDB code: 3g0u:

Chlorine binding site 1 out of 1 in 3g0u

Go back to Chlorine Binding Sites List in 3g0u
Chlorine binding site 1 out of 1 in the Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Human Dihydroorotate Dehydrogenase in Complex with A Leflunomide Derivative Inhibitor 4 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl2

b:17.5
occ:1.00
CLAF A:MDY2 0.0 17.5 1.0
CAT A:MDY2 1.7 16.1 1.0
CAN A:MDY2 2.7 15.4 1.0
CAV A:MDY2 2.7 13.5 1.0
NAO A:MDY2 2.9 12.9 1.0
CE1 A:PHE98 3.4 10.9 1.0
CD2 A:LEU359 3.5 17.4 1.0
CG A:LEU359 3.7 17.6 1.0
OAE A:MDY2 3.7 16.0 1.0
CD1 A:PHE98 3.7 11.1 1.0
CG2 A:THR360 3.8 14.9 1.0
CAU A:MDY2 4.0 19.2 1.0
CAM A:MDY2 4.0 19.4 1.0
CE2 A:TYR356 4.0 8.9 1.0
CB A:LEU359 4.0 9.9 1.0
CAR A:MDY2 4.1 15.0 1.0
C A:LEU359 4.2 11.8 1.0
N A:THR360 4.2 11.9 1.0
CB A:ALA59 4.3 10.1 1.0
O A:LEU359 4.3 13.5 1.0
CA A:THR360 4.3 12.5 1.0
CZ A:PHE98 4.5 7.3 1.0
CAL A:MDY2 4.5 19.1 1.0
CAQ A:MDY2 4.6 14.9 1.0
CB A:THR360 4.6 14.3 1.0
CD2 A:TYR356 4.6 6.5 1.0
CA A:LEU359 4.8 11.7 1.0
CAS A:MDY2 4.8 14.0 1.0
OAD A:MDY2 4.8 16.0 1.0
OAP A:MDY2 4.9 25.5 1.0
CG A:PHE98 4.9 9.4 1.0

Reference:

M.Davies, T.Heikkila, G.A.Mcconkey, C.W.G.Fishwick, M.R.Parsons, A.P.Johnson. Structure-Based Design, Synthesis, and Characterization of Inhibitors of Human and Plasmodium Falciparum Dihydroorotate Dehydrogenases J.Med.Chem. V. 52 2683 2009.
ISSN: ISSN 0022-2623
PubMed: 19351152
DOI: 10.1021/JM800963T
Page generated: Sat Dec 12 09:43:06 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy